{
    "id": 23473,
    "fullName": "ERBB2 L726F",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) L726F lies within the protein kinase domain of the Erbb2 (Her2) protein (UniProt.org). L726F confers a gain of function to the Erbb2 (Her2) protein as indicated by increased cell proliferation in culture, increased tumor growth in vivo, and localization to the perinuclear cytoplasm (PMID: 25435280).",
            "references": [
                {
                    "id": 5989,
                    "pubMedId": 25435280,
                    "title": "HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25435280"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "L726F",
    "createDate": "06/22/2016",
    "updateDate": "06/22/2016",
    "referenceTranscriptCoordinates": {
        "id": 170583,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39723628C>T",
        "cDna": "c.2176C>T",
        "protein": "p.L726F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7312,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells over expressing ERBB2 (HER2) L726F demonstrated reduced sensitivity to Tykerb (lapatinib) in culture (PMID: 18413839).",
            "molecularProfile": {
                "id": 24164,
                "profileName": "ERBB2 L726F"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 5983,
                    "pubMedId": 18413839,
                    "title": "EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18413839"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 6968,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, breast cancer cells expressing ERBB2 (HER2) L726F demonstrated resistance to Tykerb (lapatinib) in both culture and xenograft models (PMID: 25435280).",
            "molecularProfile": {
                "id": 24164,
                "profileName": "ERBB2 L726F"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 5989,
                    "pubMedId": 25435280,
                    "title": "HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25435280"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7318,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, XL647 inhibited survival of transformed cells over expressing ERBB2 (HER2) L726F in culture (PMID: 18413839).",
            "molecularProfile": {
                "id": 24164,
                "profileName": "ERBB2 L726F"
            },
            "therapy": {
                "id": 967,
                "therapyName": "XL647",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5983,
                    "pubMedId": 18413839,
                    "title": "EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18413839"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24164,
            "profileName": "ERBB2 L726F",
            "profileTreatmentApproaches": [
                {
                    "id": 9559,
                    "name": "HER2 Inhibitor",
                    "profileName": "ERBB2 L726F"
                },
                {
                    "id": 9558,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "ERBB2 L726F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170583,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39723628C>T",
            "cDna": "c.2176C>T",
            "protein": "p.L726F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 170584,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39723628C>T",
            "cDna": "c.2176C>T",
            "protein": "p.L726F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}